How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

When you buy through our links, Business Insider may earn an affiliate commission. Learn more The best convertible backpack totes are all about flexibility — something you appreciate the moment your ...

NBC Selected independently determines what we cover and recommend. When you click on or buy through our links, we earn a commission. Learn more. Mili Godio Updates Editor Bethany Heitman Commerce ...

When you buy through our links, Business Insider may earn an affiliate commission. Learn more A new semester is upon us, and a college student's most important piece of gear will likely be their ...

We independently review everything we recommend. We may make money from the links on our site. Learn more› By Kit Dillon Kit Dillon is a writer focused on bags and travel gear. He has worked for ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...